Cannabidiol for cannabis use disorder: too high hopes? - Authors' reply.
Saved in:
| Title: | Cannabidiol for cannabis use disorder: too high hopes? - Authors' reply. |
|---|---|
| Authors: | Freeman TP; Addiction and Mental Health Group, Department of Psychology, University of Bath, Bath BA2 7AY, UK; Clinical Psychopharmacology Unit, University College London, London, UK; Translational Psychiatry Research Group, Research Department of Mental Health Neuroscience, Division of Psychiatry, University College London, London, UK; National Addiction Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK. Electronic address: t.p.freeman@bath.ac.uk., Hindocha C; Clinical Psychopharmacology Unit, University College London, London, UK; Translational Psychiatry Research Group, Research Department of Mental Health Neuroscience, Division of Psychiatry, University College London, London, UK; National Institute for Health Research, University College London Hospitals Biomedical Research Centre, London, UK., Baio G; Department of Statistical Science, University College London, London, UK., Curran HV; Clinical Psychopharmacology Unit, University College London, London, UK; National Institute for Health Research, University College London Hospitals Biomedical Research Centre, London, UK. |
| Source: | The lancet. Psychiatry [Lancet Psychiatry] 2020 Oct; Vol. 7 (10), pp. 840. |
| Publication Type: | Letter; Comment |
| Journal Info: | Publisher: Elsevier Country of Publication: England NLM ID: 101638123 Publication Model: Print Cited Medium: Internet ISSN: 2215-0374 (Electronic) Linking ISSN: 22150366 NLM ISO Abbreviation: Lancet Psychiatry Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
